| Name | Title | Contact Details |
|---|
Founded in 1994 with offices in Boston and San Francisco, Spectrum Equity is a leading growth equity firm that provides capital and strategic support to innovative companies in the information economy. The firm has invested in over 140 companies and is currently investing its eighth fund with $1.25 billion in capital. Spectrum partners with exceptional entrepreneurs to build great information services, software and internet companies. Spectrum seeks to invest in companies which have defensible and sustainable business models with strong recurring revenue, significant operating leverage, and structural competitive advantages. The firm has a flexible approach to ownership and typically invests $25 – $125 million per investment, often representing the company`s first institutional investor. Spectrum plays a prominent role in helping its portfolio companies scale their business through senior management and Board recruitment, M&A, and sales & marketing optimization. Content contained in this profile and posted updates is not intended to and does not constitute legal advice or investment advice. Your use of this information in the posted update and materials linked is at your own risk. Spectrum Equity does not make any guarantee or other promise as to any results that may be obtained from using this content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. To the maximum extent permitted by law, Spectrum Equity disclaims any and all liability in the event any information, commentary, analysis, and/or opinions prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The specific companies identified in posts do not represent all of Spectrum`s investments, and no assumptions should be made that any investments identified were or will be profitable.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.
CI Capital Partners LLC is a leading North American private equity investment firm that has invested in middle-market companies since 1993. CI Capital forms partnerships with experienced management teams and entrepreneurs to build substantial businesses through add-on acquisitions, organic growth, and operational improvements. Since inception, CI Capital and its portfolio companies have made over 400 acquisitions representing more than $10 billion in enterprise value.
Fulcrum Investments Inc is a San Diego, CA-based company in the Financial Services sector.
BioCapital Investments,L.P. is a Montrí©al, QC-based company in the Financial Services sector.